Microrna-152 mediates dnmt1-regulated dna methylation in the estrogen receptor α gene

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wang, Yung Song ^a   Chou, Wen Wen ^a   Chen, Ku Chung ^a   Cheng, Hsin Yun ^a   Lin, Ruey Tay ^a,b   Juo, Suh Hang Hank ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; DNA METHYLTRANSFERASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICRORNA; MICRORNA 152; PLACEBO; SAN HUANG XIE XIN TANG; SIMVASTATIN; UNCLASSIFIED DRUG; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; ESTROGEN RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; MIRN152 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA MEDIA; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ESTROGEN RECEPTOR ALPHA GENE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LIPID DIET; LOSS OF FUNCTION MUTATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RECEPTOR GENE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; AORTA; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; AORTA; CELL MOVEMENT; CELL PROLIFERATION; DIET, HIGH-FAT; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICRORNAS; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84856269852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030635     Document Type: Article

References (42)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-181.
2. Abraham ST, Benscoter HA, Schworer CM, Singer HA, (1997) A role for Ca2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circulation Research 81: 575-584.
3. Libby P, Ridker PM, Maseri A, (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
4. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, et al. (2005) Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circulation Research 96: 172-179.
5. Libby P, Aikawa M, (2002) Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nature Medicine 8: 1257-1262.
6. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, et al. (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 1433-1439.
7. Ross R, (1999) Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 340: 115-126.
8. Schwartz SM, (1997) Smooth muscle migration in atherosclerosis and restenosis. The Journal of Clinical Investigation 100: S87-89.
9. Hiltunen MO, Yla-Herttuala S, (2003) DNA methylation, smooth muscle cells, and atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 1750-1753.
10. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomaki S, Airenne K, et al. (1999) Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 2171-2178.
11. Matouk CC, Marsden PA, (2008) Epigenetic regulation of vascular endothelial gene expression. Circulation Research 102: 873-887.
12. Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nature Reviews Genetics 3: 415-428.
13. Turunen MP, Aavik E, Yla-Herttuala S, (2009) Epigenetics and atherosclerosis. Biochimica et Biophysica Acta 1790: 886-891.
14. Dong C, Yoon W, Goldschmidt-Clermont PJ, (2002) DNA methylation and atherosclerosis. The Journal of Nutrition 132: 2406S-2409S.
15. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, et al. (2008) Detection of altered global DNA methylation in coronary artery disease patients. DNA and Cell Biology 27: 357-365.
16. Lee ME, Wang H, (1999) Homocysteine and hypomethylation. A novel link to vascular disease. Trends in Cardiovascular Medicine 9: 49-54.
17. Nakamura Y, Suzuki T, Miki Y, Tazawa C, Senzaki K, et al. (2004) Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens. Molecular and Cellular Endocrinology 219: 17-26.
18. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovascular Research 43: 985-991.
19. Ying AK, Hassanain HH, Roos CM, Smiraglia DJ, Issa JJ, et al. (2000) Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovascular Research 46: 172-179.
20. Rubanyi GM, Kauser K, Johns A, (2002) Role of estrogen receptors in the vascular system. Vascular Pharmacology 38: 81-88.
21. Li E, Bestor TH, Jaenisch R, (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
22. Okano M, Bell DW, Haber DA, Li E, (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
23. Huang J, Wang Y, Guo Y, Sun S, (2010) Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52: 60-70.
24. Braconi C, Huang N, Patel T, (2010) MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51: 881-890.
25. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104: 15805-15810.
26. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R, (2008) miR-148 targets human DNMT3b protein coding region. Rna 14: 872-877.
27. Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, et al. (2011) OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. Faseb J.
28. Farmer JA, (2000) Pleiotropic effects of statins. Curr Atheroscler Rep 2: 208-217.
29. Diomede L, Albani D, Sottocorno M, Donati MB, Bianchi M, et al. (2001) In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 21: 1327-1332.
30. Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM, et al. (2002) Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg 36: 150-157.
31. Nishimura T, Vaszar LT, Faul JL, Zhao G, Berry GJ, et al. (2003) Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 108: 1640-1645.
32. Wang YS, Lin RT, Cheng HY, Yang SF, Chou WW, et al. (2011) Anti-atherogenic effect of San-Huang-Xie-Xin-Tang, a traditional Chinese medicine, in cultured human aortic smooth muscle cells. Journal of Ethnopharmacology 133: 442-447.
33. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH, (2002) Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 12: 158-164.
34. Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, et al. (2006) Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. The Journal of Clinical Endocrinology and Metabolism 91: 2713-2720.
35. Okubo T, Urabe M, Tsuchiya H, Iwasa K, Yokota K, et al. (2000) Effect of estrogen and progesterone on gene expression of growth regulatory molecules and proto-oncogene in vascular smooth muscle cells. Endocrine Journal 47: 205-214.
36. Seeger H, Wallwiener D, Mueck AO, (2001) Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. Menopause 8: 5-9.
37. Newman PE, (1999) Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis? Medical Hypotheses 53: 421-424.
38. Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, et al. (2007) Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA and Cell Biology 26: 603-611.
39. Hiltunen MO, Turunen MP, Hakkinen TP, Rutanen J, Hedman M, et al. (2002) DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vascular Medicine 7: 5-11.
40. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, et al. (2004) DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. The Journal of Biological Chemistry 279: 29147-29154.
41. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32: e38.
42. Ashton AW, Yokota R, John G, Zhao S, Suadicani SO, et al. (1999) Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A2. The Journal of Biological Chemistry 274: 35562-35570.